Stocktoria
Concord Medical Services Holdings Ltd CCM
NYSE · stock · Services-Offices & Clinics of Doctors of Medicine · website · IPO 2009-12-11
Concord Medical Services Holdings Ltd financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65.9M | $52.6M | $75.7M | $68.4M | $76.2M | $34.2M | $28.5M | $27.8M | $91.4M | $455.0M |
| Gross profit | $3.7M | -$10.8M | -$10.8M | -$22.1M | -$8.9M | $2.0M | -$2.3M | $2.9M | $15.1M | $24.3M |
| Operating income | -$37.4M | -$72.9M | -$65.2M | -$76.1M | -$71.9M | -$48.4M | -$62.8M | -$43.5M | -$32.6M | -$24.3M |
| Interest expense | — | — | $23.3M | $17.4M | $11.6M | $12.5M | $4.1M | $6.7M | $13.8M | $12.9M |
| Income tax | $867,000 | -$2.4M | -$3.5M | -$10.3M | -$1.0M | -$5.8M | -$5.6M | $5.0M | $4.9M | $8.7M |
| Net income | -$13.3M | -$42.2M | -$41.9M | -$71.0M | -$42.6M | -$47.5M | -$44.1M | -$34.2M | -$43.7M | -$37.7M |
| EPS (diluted) | $-0.10 | $-0.32 | $-0.32 | $-0.54 | $-6.26 | $-5.11 | — | — | — | $-0.29 |
| Operating cash flow | -$28.9M | -$54.5M | -$38.9M | -$31.4M | -$56.4M | -$35.2M | -$28.1M | -$5.6M | $4.1M | -$78.1M |
| Free cash flow | -$36.9M | -$75.1M | -$54.9M | -$63.7M | -$100.2M | -$61.0M | -$61.5M | -$29.7M | -$9.9M | -$89.4M |
| Cash & equivalents | $42.6M | $29.6M | $8.2M | $22.9M | $24.7M | $51.2M | $10.7M | $58.9M | $98.2M | $189.9M |
| Inventory | $6.6M | $4.6M | $5.7M | $12.3M | $6.0M | $3.3M | $624,000 | $488,000 | $966,000 | $853,000 |
| Total assets | $936.3M | $921.5M | $852.7M | $870.6M | $977.6M | $817.6M | $617.3M | $666.9M | $532.6M | $465.0M |
| Total liabilities | $671.7M | $699.9M | $606.6M | $578.4M | $547.1M | $449.6M | $345.9M | $336.2M | $376.6M | $287.6M |
| Shareholders' equity | -$300.7M | -$312.4M | -$298.9M | $292.2M | -$215.0M | -$101.6M | -$17.6M | $80.5M | $156.0M | $177.4M |
Growth · year-over-year · Revenue CAGR -19.3%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +25.2% | -30.5% | +10.6% | -10.2% | +123.0% | +20.0% | +2.6% | -69.6% | -79.9% | +378.1% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.